Structure of human ACE gives new insights into inhibitor binding and design
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (8), 391-394
- https://doi.org/10.1016/s0165-6147(03)00196-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Deglycosylation, processing and crystallization of human testis angiotensin-converting enzymeBiochemical Journal, 2003
- Crystal structure of Drosophila angiotensin I‐converting enzyme bound to captopril and lisinopril1FEBS Letters, 2003
- Crystal structure of the human angiotensin-converting enzyme–lisinopril complexNature, 2003
- Drugs targeting the renin–angiotensin–aldosterone systemNature Reviews Drug Discovery, 2002
- Crystal Structure of a Novel Carboxypeptidase from the Hyperthermophilic Archaeon Pyrococcus furiosusStructure, 2002
- Structure of neurolysin reveals a deep channel that limits substrate accessProceedings of the National Academy of Sciences, 2001
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000
- Cloning and Expression of an Evolutionary Conserved Single-domain Angiotensin Converting Enzyme from Drosophila melanogasterJournal of Biological Chemistry, 1995
- Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.Proceedings of the National Academy of Sciences, 1989
- Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.Proceedings of the National Academy of Sciences, 1988